- Home
- LAB vs PNNT Comparison
LAB vs PNNT Comparison
Compare LAB & PNNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAB
- PNNT
- Stock Information
- Founded
- LAB 1999
- PNNT 2007
- Country
- LAB United States
- PNNT United States
- Employees
- LAB N/A
- PNNT N/A
- Industry
- LAB Biotechnology: Laboratory Analytical Instruments
- PNNT Finance: Consumer Services
- Sector
- LAB Industrials
- PNNT Finance
- Exchange
- LAB Nasdaq
- PNNT Nasdaq
- Market Cap
- LAB 451.0M
- PNNT 462.3M
- IPO Year
- LAB 2011
- PNNT 2007
- Fundamental
- Price
- LAB $1.12
- PNNT $6.48
- Analyst Decision
- LAB Buy
- PNNT Hold
- Analyst Count
- LAB 2
- PNNT 3
- Target Price
- LAB $2.50
- PNNT $6.00
- AVG Volume (30 Days)
- LAB 999.6K
- PNNT 535.4K
- Earning Date
- LAB 05-06-2025
- PNNT 05-12-2025
- Dividend Yield
- LAB N/A
- PNNT 14.81%
- EPS Growth
- LAB N/A
- PNNT 11.30
- EPS
- LAB N/A
- PNNT 0.83
- Revenue
- LAB $169,687,000.00
- PNNT $143,689,000.00
- Revenue This Year
- LAB N/A
- PNNT N/A
- Revenue Next Year
- LAB $12.77
- PNNT N/A
- P/E Ratio
- LAB N/A
- PNNT $7.79
- Revenue Growth
- LAB 33.86
- PNNT N/A
- 52 Week Low
- LAB $0.95
- PNNT $5.72
- 52 Week High
- LAB $2.74
- PNNT $8.04
- Technical
- Relative Strength Index (RSI)
- LAB 47.61
- PNNT 48.54
- Support Level
- LAB $0.95
- PNNT $6.34
- Resistance Level
- LAB $1.21
- PNNT $6.60
- Average True Range (ATR)
- LAB 0.10
- PNNT 0.15
- MACD
- LAB -0.01
- PNNT 0.03
- Stochastic Oscillator
- LAB 43.42
- PNNT 77.68
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.
About PNNT PennantPark Investment Corporation
Pennant Park Investment Corp is a closed-end, non-diversified investment company. Its investment objective is to generate current income and capital appreciation also seeking to preserve capital through debt and equity investments. The company focuses on investing in United States middle-market companies that offer attractive risk-reward to investors and to create a diversified portfolio that includes senior secured debt, mezzanine debt, and equity investments. It generates majority of its revenue from interest and dividends received from investments made.